| NCT ID | NCT05349370 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska University Hospital |
| Condition | Sepsis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-12-28 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-12-28 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lactate kinetics will be studied in hospitalized septic patients using a bolus injection of stable isotopically labeled lactate.
Eligibility Criteria
Inclusion Criteria: * Sepsis * Age \>17 years * Arterial catheter * Lactate \> 2 mmol at any time point prior to inclusion Exclusion Criteria: * Mitochondrial defect * Degenerative muscle disease * Terminal liver failure
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05349370 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05349370 currently recruiting?
Yes, NCT05349370 is actively recruiting participants. Contact the research team at jonathan.grip@regionstockholm.se for enrollment information.
Where is the NCT05349370 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT05349370 clinical trial?
NCT05349370 is sponsored by Karolinska University Hospital. The trial plans to enroll 60 participants.